| 臺大學術典藏 |
2022-02-21T03:52:39Z |
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancer
|
JIH-HSIANG LEE; Lin Y.-L.; Hsu W.-H.; Chen H.-Y.; Chang Y.-C.; Yu C.-J.; Shih J.-Y.; Lin C.-C.; Chen K.-Y.; Ho C.-C.; Laio W.-Y.; Yang P.-C.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:38Z |
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Non-Small-Cell Lung Cancer Patients with Leptomeningeal Carcinomatosis
|
Liao B.-C.; JIH-HSIANG LEE; Lin C.-C.; Chen Y.-F.; Chang C.-H.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:35Z |
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study
|
Lin C.-C.; Shih J.-Y.; Yu C.-J.; Ho C.-C.; Liao W.-Y.; JIH-HSIANG LEE; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:35Z |
Tumor PD-L1 expression and clinical outcomes in advanced-stage non-small cell lung cancer patients treated with nivolumab or pembrolizumab: Real-world data in Taiwan
|
Lin S.-Y.; Yang C.-Y.; Liao B.-C.; Ho C.-C.; Liao W.-Y.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Hsu W.-H.; Su K.-Y.; Chang Y.-L.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:34Z |
Best Response According to RECIST During First-line EGFR-TKI Treatment Predicts Survival in EGFR Mutation-positive Non�VSmall-cell Lung Cancer Patients
|
Wu T.-H.; Hsiue E.H.-C.; JIH-HSIANG LEE; Lin C.-C.; Liao W.-Y.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-21T03:52:34Z |
Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors
|
Liao B.-C.; Bai Y.-Y.; JIH-HSIANG LEE; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; Yu C.-J.; Chih-Hsin Yang J.; Yang P.-C. |
| 臺大學術典藏 |
2022-02-21T03:52:33Z |
Clinical outcomes and secondary epidermal growth factor receptor (EGFR) T790M mutation among first-line gefitinib, erlotinib and afatinib-treated non-small cell lung cancer patients with activating EGFR mutations
|
Lin Y.-T.; Chen J.-S.; Liao W.-Y.; Ho C.-C.; Hsu C.-L.; Yang C.-Y.; Chen K.-Y.; JIH-HSIANG LEE; Lin Z.-Z.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:32Z |
Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:31Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; JIH-HSIANG LEE; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-21T03:52:30Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M�VPositive NSCLC
|
Liao B.-C.; Hsu W.-H.; JIH-HSIANG LEE; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; Yu C.-J.; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2022-02-14T07:10:40Z |
Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib
|
Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; Su K.-Y.; YIH-LEONG CHANG; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. |
| 臺大學術典藏 |
2022-02-14T07:10:38Z |
Vorinostat combined with brigatinib overcomes acquired resistance in EGFR-C797S-mutated lung cancer
|
Lin C.-Y.; Huang K.-Y.; Lin Y.-C.; Yang S.-C.; Chung W.-C.; YIH-LEONG CHANG; Shih J.-Y.; Ho C.-C.; Lin C.-A.; Shih C.-C.; Chang Y.-H.; Kao S.-H.; Yang P.-C. |
| 臺大學術典藏 |
2022-02-14T03:44:22Z |
A myeloid leukemia factor homolog involved in encystation-induced protein metabolism in Giardia lamblia
|
Wu J.-H.; Tung S.-Y.; Ho C.-C.; Su L.-H.; Gan S.-W.; Liao J.-Y.; Cho C.-C.; Lin B.-C.; Chiu P.-W.; Pan Y.-J.; Kao Y.-Y.; Liu Y.-C.; CHIN-HUNG SUN |
| 臺大學術典藏 |
2022-02-08T03:50:25Z |
HAI-2 as a novel inhibitor of plasmin represses lung cancer cell invasion and metastasis
|
Wu S.-R.; Lin C.-H.; Shih H.-P.; Chun-Jung Ko; Lin H.-Y.; Lan S.-W.; Lin H.-H.; Tu H.-F.; Ho C.-C.; Huang H.-P.; Lee M.-S. |
| 臺大學術典藏 |
2022-02-08T03:50:22Z |
Afatinib exerts immunomodulatory effects by targeting the pyrimidine biosynthesis enzyme CAD
|
Tu H.-F.; Chun-Jung Ko; Lee C.-T.; Lee C.-F.; Lan S.-W.; Lin H.-H.; Lin H.-Y.; Ku C.-C.; Lee D.-Y.; Chen I.-C.; Chuang Y.-H.; Ca?o-Ochoa F.D.; Ramon-Maiques S.; Ho C.-C.; Lee M.-S.; Chang G.-D. |
| 國立成功大學 |
2022 |
RAM: Exploiting Restrained and Approximate Management for Enabling Neural Network Training on NVM-based Systems
|
Ho, C.-C.;Wang, Wang W.-C.;Chen, S.-Y.;Li, Y.-C.;Chiang, K.-C. |
| 國立成功大學 |
2022 |
RNA-seq Quantification on Processing in memory Architecture: Observation and Characterization
|
Chen, L.-C.;Yu, S.-Q.;Ho, C.-C.;Chang, Y.-H.;Chang, D.-W.;Wang, Wang W.-C.;Chang, Y.-M. |
| 國立成功大學 |
2022 |
RUSM: Harnessing Unused Resources in 3D NAND SSD to Enhance Reading Performance
|
Alhasan, H.;Chen, Y.-C.;Ho, C.-C.;Kuo, T.-W. |
| 國立成功大學 |
2022 |
On enduring more data through enabling page rewrite capability on multi-level-cell flash memory
|
Chang, Y.-M.;Ho, C.-C.;Tsao, C.-W.;Liao, S.-H.;Wang, Wang W.-C.;Kuo, T.-W.;Chang, Y.-H. |
| 國立成功大學 |
2022 |
Evaluation of the Effect of Voice Technology in a Game Teaching E-Book on English Learning
|
Shieh, M.-D.;Ho, C.-C.;Hsu, F.-C.;Yang, C.-C. |
| 臺大學術典藏 |
2021-11-18T05:54:44Z |
Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts
|
Lee P.-J.; Ho C.-C.; Ho H.; Chen W.-J.; Lin C.-H.; Lai Y.-H.; Juan Y.-C.; Chu W.-C.; Lee J.-H.; SHENG-FANG SU; Chen H.-Y.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C.; Chen H.-W. |
| 臺大學術典藏 |
2021-11-18T05:54:43Z |
The M1/M2 spectrum and plasticity of malignant pleural effusion-macrophage in advanced lung cancer
|
Wu M.-F.; Lin C.-A.; Yuan T.-H.; Yeh H.-Y.; SHENG-FANG SU; Guo C.-L.; Chang G.-C.; Li K.-C.; Ho C.-C.; Chen H.-W. |
| 臺大學術典藏 |
2021-11-03T05:24:55Z |
Serial Plasma Cell-Free Circulating Tumor DNA Tests Identify Genomic Alterations for Early Prediction of Osimertinib Treatment Outcome in EGFR T790M–Positive NSCLC
|
Liao B.-C.; Hsu W.-H.; Lee J.-H.; Yang C.-Y.; Tsai T.-H.; Liao W.-Y.; Ho C.-C.; Lin C.-C.; Shih J.-Y.; CHONG-JEN YU; Soo R.A.; Yang J.C.-H. |
| 臺大學術典藏 |
2021-11-03T05:24:55Z |
Trait mindfulness and depressive symptoms in non-small cell lung cancer patients: the mediating roles of quality of life and meaning in life
|
Hsieh C.-C.; Ho C.-C.; Lin Z.-Z.; CHONG-JEN YU; Jow G.-M.; Huang F.-Y.; Shih J.-Y.; Hsiao F.-H. |
| 臺大學術典藏 |
2021-11-03T05:24:52Z |
The Short- and Long-term Causal Relationships Between Self-compassion, Trait Mindfulness, Caregiver Stress, and Depressive Symptoms in Family Caregivers of Patients with Lung Cancer
|
Hsieh C.-C.; Lin Z.-Z.; Ho C.-C.; CHONG-JEN YU; Chen H.-J.; Chen Y.-W.; Hsiao F.-H. |
